Liang Y, Dai X, Chen J, Zeng X, Qing X, Huang J, et al. Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional study. Int J Surg. 2025;111:891–903.

Article  PubMed  Google Scholar 

Li M, Xu S, Yang Q, Zheng Z, Zhang X, Liu H, et al. Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031. Int J Gynecol Obstet. 2025.

Momenimovahed Z, Mazidimoradi A, Maroofi P, Allahqoli L, Salehiniya H, Alkatout I. Global, regional and national burden, incidence, and mortality of cervical cancer. Cancer Rep. 2023;6: e1756.

Google Scholar 

Bejar FG, Oaknin A, Williamson C, Mayadev J, Peters PN, Secord AA, et al. Novel therapies in gynecologic cancer. Am Soc Clin Oncol Educ Book. 2022. https://doi.org/10.1200/EDBK_351294.

Article  PubMed  Google Scholar 

Majumder A, Ghorui S, Sengupta S, Bhattacharya M. Identification of potential inhibitors of PTEN tumor suppressor gene from phytochemical constituents found in tomato (Solanum lycopersicum) via biocomputational analysis. Int J Biomed Investig. 2024;7:19–31.

Article  Google Scholar 

Nagarajan S, Mohandas S, Ganesan K, Xu B, Ramkumar KM. New insights into dietary pterostilbene: sources, metabolism, and health promotion effects. Molecules. 2022;27(19):6316.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J Agric Food Chem. 2004;52(15):4713–9.

Article  PubMed  CAS  Google Scholar 

Liu Y, You Y, Lu J, Chen X, Yang Z. Recent advances in synthesis, bioactivity, and pharmacokinetics of Pterostilbene, an important analog of resveratrol. Molecules. 2020;25(21):5166.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zou Y, Wang X, Bi D, Fu J, Han J, Guo Y, et al. Pterostilbene nanoparticles with small particle size show excellent anti-breast cancer activity in vitro and in vivo. Nanotechnology. 2021;32: 32.

Article  Google Scholar 

Zhang Y, Shang Z, Gao C, Du M, Xu S, Song H, et al. Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. AAPS PharmSciTech. 2014;15(4):1000–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, et al. Analysis of safety from a human clinical trial with pterostilbene. J Toxicol. 2013;2013: 463595.

Article  PubMed  PubMed Central  Google Scholar 

Riche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, et al. Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial. Evidence Based Complement Altern Med. 2014;2014: 459165.

Article  Google Scholar 

Ali MA, Kaleem N, Ali A, Khan N, Khaliq M, Arif N, et al. Pterostilbene as a multifaceted anticancer agent: molecular mechanisms, therapeutic potential and future directions. Med Oncol. 2025;42:1–22.

Article  Google Scholar 

Butt G, Attar R, Tabassum S, Aras A, Qadir MI, Ozbey U, et al. Regulation of signal transduction cascades by Pterostilbenes in different cancers: is it a death knell for oncogenic pathways. Cell Mol Biol. 2017;63(12):5–10.

Article  PubMed  Google Scholar 

Chen RJ, Kuo HC, Cheng LH, Lee YH, Chang WT, Wang BJ, et al. Apoptotic and nonapoptotic activities of pterostilbene against cancer. Int J Mol Sci. 2018;19(1): 287.

Article  PubMed  PubMed Central  Google Scholar 

Levenson A, Kumar A. Pterostilbene as a potent chemopreventive agent in cancer. Natural products for cancer chemoprevention: single compounds and combinations. Cham: Springer; 2020. p. 48–108.

Google Scholar 

Wang YL, Shen Y, Xu JP, Han K, Zhou Y, Yang S, et al. Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating MIR-663b. Acta Pharmacol Sin. 2017;38(10):1394–400.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gołąbek-Grenda A, Kaczmarek M, Juzwa W, Olejnik A. Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways. Sci Rep. 2023;13(1):11468.

Article  PubMed  PubMed Central  Google Scholar 

Chatterjee K, AlSharif D, Mazza C, Syar P, Sharif MA, Fata JE. Resveratrol and pterostilbene exhibit anticancer properties involving the downregulation of HPV oncoprotein E6 in cervical cancer cells. Nutrients. 2018;10(2): 243.

Article  PubMed  PubMed Central  Google Scholar 

Bin WH, Da LH, Xue Y, Jing BW. Pterostilbene (3’,5’-dimethoxy-resveratrol) exerts potent antitumor effects in HeLa human cervical cancer cells via disruption of mitochondrial membrane potential, apoptosis induction and targeting m-TOR/PI3K/Akt signalling pathway. J BUON. 2018;23(5):1384–9.

Google Scholar 

Shin HJ, Han JM, Choi YS, Jung HJ. Pterostilbene suppresses both cancer cells and cancer stem-like cells in cervical cancer with superior bioavailability to resveratrol. Molecules. 2020;25(1):228.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li X, Yu D, Wang Q, Chen Y, Jiang H. Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach. Chem Biol Interact. 2024;396: 111058.

Article  PubMed  CAS  Google Scholar 

Chatterjee K, Mukherjee S, Vanmanen J, Banerjee P, Fata JE. Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Front Oncol. 2019;9:352.

Article  PubMed  PubMed Central  Google Scholar 

Wen W, Lowe G, Roberts CM, Finlay J, Han ES, Glackin CA, et al. Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer. Sci Rep. 2017;7(1):12754.

Article  PubMed  PubMed Central  Google Scholar 

Dellinger TH, Wu X, Cho H, Yost SE, Ruel NH, Invernizzi M, et al. Differential gene expression analysis of a phase II randomized clinical trial of patients with endometrial cancer (EC) treated with megestrol acetate ± pterostilbene. J Clin Oncol. 2024;42:e17601–e17601.

Article  Google Scholar 

Senguttuvan RN, Cho H, Wu X, Frankel PH, Ruel N, Yost SE, et al. The anti-cancer role of pterostilbene in endometrial cancer: a phase II prospective, randomized, window-of-opportunity clinical trial with megestrol acetate. Antioxidants. 2025;14:345.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li Z, Zhang J, You S, Zhang J, Zhang Y, Akram Z, et al. Pterostilbene upregulates MICA/B via the PI3K/AKT signaling pathway to enhance the capability of natural killer cells to kill cervical cancer cells. Exp Cell Res. 2024;435(2): 113933.

Article  PubMed  CAS  Google Scholar